Gut Microbiota Dysbiosis Is a Key Driver of Inflammaging in Chronic Kidney Disease
Cells · 27.06.2026 · 15 (13) · 1171
DOI: 10.3390/cells15131171 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 27.06.2026. Verfasst von Emanuele Parodi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology and Dialysis Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy. Hauptthemen laut MEDLINE: Dysbiosis, Renal Insufficiency, Chronic, Gastrointestinal Microbiome, Inflammation. Die Arbeit nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The role of gut microbiota and intestinal dysbiosis in promoting inflammaging in chronic kidney disease (CKD) has been the focus of intense research over the last years. Some alterations at the phyla level, such as abundance of Proteobacteria and reduction in Firmicutes/Bacteroidites (F/B) ratio and saccarolytic populations, have been consistently reported in CKD. Other mechanisms include microbial translocation through a “leaky gut” and subsequent molecular mimicry, immune dysregulation (unbalance between T reg and Th17 subsets), and epigenetic interactions. Alterations of metabolic pathways and of bacterial metabolites, such as butyrate and other short chain fatty acids (SCFA), also appear to play a key role in modulating progression of CKD. On the other hand, microbiota-based therapy appears promising and includes diet, prebiotics, probiotics, synbiotics, postbiotics and fecal microbiota transplantation (FMT). Modulation of microbiota could correct critical alterations, such as F/B ratio and T reg/Th17 unbalance, blunting inflammaging and potentially reducing progression of CKD and cardiovascular disease. Despite current limitations, gut microbiota is emerging as a powerful environmental factor which could be harnessed to interfere with key mechanisms leading to inflammaging in CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology and Dialysis Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
- Internal Medicine Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
- Department of Translational Medicine, Università del Piemonte Orientale (UPO), 28100 Novara, Italy.
- Microbiology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
- Gastroenterology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy.
- Nephrology and Transplant Unit, Maggiore della Carita University Hospital, 28100 Novara, Italy.
ORCID-Profile: Emanuele Parodi, Paolo Bottino, Franca Gotta, Andrea Rocchetti, Vincenzo Cantaluppi, Marco Quaglia
Zitieren
APA
Parodi, E., Castello, L. M., Bottino, P., Gotta, F., Novi, M., Orsello, M., Rocchetti, A., Prenna, S., Cantaluppi, V., & Quaglia, M. (2026). Gut Microbiota Dysbiosis Is a Key Driver of Inflammaging in Chronic Kidney Disease. Cells, 15(13), 1171. https://doi.org/10.3390/cells15131171
Vancouver
Parodi E, Castello LM, Bottino P, Gotta F, Novi M, Orsello M, et al. Gut Microbiota Dysbiosis Is a Key Driver of Inflammaging in Chronic Kidney Disease. Cells. 2026;15(13):1171. doi:10.3390/cells15131171
BibTeX
@article{Parodi2026,
author = {Parodi, Emanuele and Castello, Luigi Mario and Bottino, Paolo and Gotta, Franca and Novi, Marialuisa and Orsello, Marco and Rocchetti, Andrea and Prenna, Stefania and Cantaluppi, Vincenzo and Quaglia, Marco},
title = {Gut Microbiota Dysbiosis Is a Key Driver of Inflammaging in Chronic Kidney Disease},
journal = {Cells},
year = {2026},
volume = {15},
number = {13},
pages = {1171},
doi = {10.3390/cells15131171}
}
EUVIMED